Recent advances in biomimetic nanodelivery systems for the treatment of depression
Depression and cognitive disorders remain major challenges in healthcare, with conventional treatments often facing limitations such as slow onset, side effects, and poor drug delivery to the brain.Biomimetic nanodelivery systems, including nanozymes, cell membrane-based systems, 2004 hyundai santa fe catalytic converter and exosomes, have emerged